The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study
暂无分享,去创建一个
L. Bouter | G. Nijpels | J. Dekker | R. Heine | C. Stehouwer | F. Vegt
[1] J. Widimský,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.
[2] K. Flegal,et al. Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria , 1997, Diabetes Care.
[3] E. Barrett-Connor. Does Hyperglycemia Really Cause Coronary Heart Disease? , 1997, Diabetes Care.
[4] Ralph B D'Agostino,et al. Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.
[5] M. Engelgau,et al. Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited , 1997, Diabetes Care.
[6] R. Bain,et al. Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.
[7] M. Harris,et al. Undiagnosed Diabetes or Impaired Glucose Tolerance and Cardiovascular Risk , 1997, Diabetes Care.
[8] S. Haffner,et al. The Insulin Resistance Syndrome Revisited , 1996, Diabetes Care.
[9] H. Valkenburg,et al. Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study , 1995, Diabetes Care.
[10] R. Hanson,et al. Which Test for Diagnosing Diabetes? , 1995, Diabetes Care.
[11] R. Klein. Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.
[12] R. Hanson,et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.
[13] M. Harris,et al. Fasting Plasma Glucose in Screening for NIDDM in the U. S. and Israel , 1994, Diabetes Care.
[14] T. Orchard. From Diagnosis and Classification to Complications and Therapy: DCCT Part II? , 1994, Diabetes Care.
[15] T. Orchard,et al. Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective , 1992, Diabetes Care.
[16] S. Haffner,et al. Dyslipidemia in type II Diabetes: Implications for Therapeutic Intervention , 1991, Diabetes Care.
[17] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[18] P. Zimmet,et al. Determining Diabetes Prevalence: a Rational Basis for the Use of Fasting Plasma Glucose Concentrations? , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[19] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[20] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[21] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.
[22] R. Hanson,et al. Diagnosing diabetes mellitus – do we need new criteria? , 1997, Diabetologia.
[23] P. Björntorp,et al. Measurement of regional distribution of adipose tissue. , 1988 .